Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Other Non-Current Liabilities (2020 - 2025)

Beauty Health (SKIN) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $1.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.9 million, a N/A change, with the full-year FY2024 number at $488000.0, down 86.27% from a year prior.
  • Other Non-Current Liabilities was $1.9 million for Q3 2025 at Beauty Health, up from $349000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $93.8 million in Q4 2021 to a low of $11000.0 in Q1 2022.
  • A 5-year average of $14.2 million and a median of $1.9 million in 2024 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 99.98% in 2022, then skyrocketed 223081.82% in 2023.
  • Beauty Health's Other Non-Current Liabilities stood at $93.8 million in 2021, then tumbled by 83.51% to $15.5 million in 2022, then tumbled by 77.02% to $3.6 million in 2023, then tumbled by 86.27% to $488000.0 in 2024, then surged by 285.66% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Other Non-Current Liabilities are $1.9 million (Q3 2025), $349000.0 (Q2 2025), and $1.8 million (Q1 2025).